Respiratory

Cystic Fibrosis Carriers at Increased Risk of Digestive Symptoms

Published: Thursday, October 17, 2019, 12:00 p.m. U.S. Central Time Media Contact: Ann Klinck, 301.634.7342, press@ashg.org Findings Reported at ASHG 2019 Annual Meeting HOUSTON, Texas – Researchers have found that carriers of the most common genetic variant that causes cystic fibrosis experience some symptoms similar to those of people with cystic fibrosis. These findings were... Read More

Trainee Paper Spotlight: Ma’en Obeidat

Trainee Author: Ma’en Obeidat, PhD Postdoctoral Fellow University of British Columbia Centre for Heart Lung Innovation Obeidat, Ma’en, Hao, Ke, Bossé, Yohan, Nickle, David C., Nie, Yunlong, Postma, Dirkje S., Laviolette, Michel, Sandford, Andrew J., Daley, Denise D., Hogg, James C., Elliott, W. Mark Fishbane, Nick, Timens, Wim, Hysi, Pirro G., Kaprio, Jaakko, Wilson, James... Read More

DNA variants may influence response to inhaled bronchodilators by patients with COPD, scientists report at ASHG 2013

DNA variants may influence response to inhaled bronchodilators by patients with COPD, scientists report at ASHG 2013

NEWS For more information: Cathy Yarbrough press@ashg.org sciencematter@yahoo.com 858-243-1814 Embargo: 8 a.m. ET, Friday, Oct. 25, 2013 Several novel gene variants may help explain the response of patients with chronic obstructive pulmonary disease (COPD) to inhaled bronchodilators, according to a meta-analysis reported today (Oct. 25) at the American Society of Human Genetics 2013 meeting in... Read More

ASHG uses cookies to provide you with a secure and custom web experience. Privacy Policy